These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28327605)

  • 1. Ginsenoside Rb1 protects against ischemia/reperfusion-induced myocardial injury via energy metabolism regulation mediated by RhoA signaling pathway.
    Cui YC; Pan CS; Yan L; Li L; Hu BH; Chang X; Liu YY; Fan JY; Sun K; -Li Q; Han JY
    Sci Rep; 2017 Mar; 7():44579. PubMed ID: 28327605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
    Li G; Qian W; Zhao C
    Can J Physiol Pharmacol; 2016 Jan; 94(1):97-103. PubMed ID: 26550918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats.
    Wu Y; Xia ZY; Dou J; Zhang L; Xu JJ; Zhao B; Lei S; Liu HM
    Mol Biol Rep; 2011 Oct; 38(7):4327-35. PubMed ID: 21113666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
    Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
    PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway.
    Li CY; Yang P; Jiang YL; Lin Z; Pu YW; Xie LQ; Sun L; Lu D
    Biomed Pharmacother; 2020 May; 125():109913. PubMed ID: 32006902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway.
    Xie Y; Ge CL; Zhang ZY; Fei GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6371-6379. PubMed ID: 32572934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
    Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B.
    Yang L; Zhang Y; Zhu M; Zhang Q; Wang X; Wang Y; Zhang J; Li J; Yang L; Liu J; Liu F; Yang Y; Kang L; Shen Y; Qi Z
    Free Radic Biol Med; 2016 Dec; 101():1-9. PubMed ID: 27667182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I.
    Jiang L; Yin X; Chen YH; Chen Y; Jiang W; Zheng H; Huang FQ; Liu B; Zhou W; Qi LW; Li J
    Theranostics; 2021; 11(4):1703-1720. PubMed ID: 33408776
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Chen XG; Lv YX; Zhao D; Zhang L; Zheng F; Yang JY; Li XL; Wang L; Guo LY; Pan YM; Yan YW; Chen SY; Wang JN; Tang JM; Wan Y
    Mol Cell Biochem; 2016 Feb; 413(1-2):9-23. PubMed ID: 26769665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
    Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
    Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury.
    He K; Yan L; Pan CS; Liu YY; Cui YC; Hu BH; Chang X; Li Q; Sun K; Mao XW; Fan JY; Han JY
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1764-76. PubMed ID: 25305180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction.
    Wang Z; Li M; Wu WK; Tan HM; Geng DF
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):443-52. PubMed ID: 18679782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B‑cell lymphoma/B‑cell lymphoma‑associated X protein pathway.
    Wang Y; Hu Z; Sun B; Xu J; Jiang J; Luo M
    Mol Med Rep; 2015 Jun; 11(6):4518-24. PubMed ID: 25672441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
    Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
    Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin/NFκB protects against ischemia-induced necrotic cardiomyocyte death.
    Díaz A; Humeres C; González V; Gómez MT; Montt N; Sanchez G; Chiong M; García L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):451-7. PubMed ID: 26449460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.